Sanofi Consumer Healthcare India Limited reports Q3’25 results
Sanofi Consumer Healthcare India Limited (BSE:544250 I NSE: SANOFICONR) releases its financial results for the third quarter demonstrating growth across key business segments.
Driven by exports and domestic business, revenue growth for the quarter stood at 46% year-on-year for 2025. Profit after tax (PAT) for Q3 reached ₹629 million, a 40% increase over year-on-year basis.
Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India Limited: “Our third-quarter results reflect the strength of our diversified portfolio driving sustained growth momentum this quarter. The domestic business demonstrates good performance, with exports providing additional impetus to revenue growth. All our voluntarily recalled products have successfully re-established their market presence within the year. Anchored in science and guided by purpose, we remain committed to making self-care simpler, more accessible and more effective for every consumer.”
Note: Quarter and nine months are not directly comparable due to the demerger and voluntary recall of certain variants of key brands in the domestic market.
--------------------------------------------------------------------------------
About Sanofi Consumer Healthcare India Limited.
Sanofi Consumer Healthcare India Limited (SCHIL) has emerged as a distinct legal entity following its demerger from Sanofi India Limited. This demerger, executed under the Scheme of Arrangement, was sanctioned by the Mumbai bench of the National Company Law Tribunal and became effective on 1st June 2024. In alignment with Sanofi's global strategy, SCHIL is now operating independently, with a dedicated focus on the Consumer Healthcare sector.
With an agile business model and strong brands, SCHIL is one of the leading players in India's consumer healthcare market. Leveraging its global experience in consumer healthcare, Sanofi Consumer Healthcare India Limited (SCHIL) aims to enhance customer wellbeing through its portfolio of products which encompasses Allergy, Digestive Wellness, Pain Care and Multivitamins. SCHIL’s key brands include Allegra®, DePURA®, Avil® and Combiflam®. They are dedicated to building a healthier future for their customers by empowering people to take control of their health, through self-care and by addressing their everyday health concerns.
